ALK-Abello A/S (AKBLF)
35.80
0.00 (0.00%)
USD |
OTCM |
Feb 05, 16:00
ALK-Abello Market Cap : 7.932B for Feb. 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 208.63B |
| Genmab A/S | 19.11B |
| Ascendis Pharma A/S | 13.58B |
| Evaxion AS | 21.41M |
| IO Biotech, Inc. | 23.07M |
Market Cap Related Metrics
| PE Ratio | 48.56 |
| PS Ratio | 8.811 |
| PEG Ratio | 1.132 |
| Price to Book Value | 8.163 |
| Price to Free Cash Flow | 196.49 |
| Price | 35.80 |
| Earnings Yield | 2.06% |
| PEGY Ratio | 1.132 |
| Operating PE Ratio | 36.29 |
| Normalized PE Ratio | 48.56 |